{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_16", "document_index": 84, "latency_s": 0.7780542999971658, "prompt_toks": 6422, "completion_toks": 80, "relevance_score": 6.540437e-06}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    United States: Cannabidiol is legal under the 2018 Farm Bill[37]. The rest of the cannabis plant (anything with more than 0.3% Delta-9-THC) is still under Schedule I of the Controlled Substances Act.[citation needed]\n\nExternal links\n\nCannabidiol (Wikipedia)\n\nCannabidiol (Isomer Design)\n\nCannabidiol (Drugs-Forum)\n\nProject CBD\n\nLiterature\n\nMechoulam, R., Peters, M., Murillo-Rodríguez, E., & Hanuš, L.O. (2007). Cannabidiol--recent advances. Chemistry & Biodiversity, 4 8, 1678-92.\n\nMechoulam, R., Parker, L. A., & Gallily, R. (2002). Cannabidiol: an overview of some pharmacological aspects. The Journal of Clinical Pharmacology, 42(S1).\n\nDevinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., ... & Martinez‐Orgado, J. (2014). Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia, 55(6), 791-802. https://doi.org/0.1111/epi.12631\n\nReferences\n\n\n                    Context: \n                    This chunk provides information on the legal status of cannabidiol in the United States, highlighting its legality under the 2018 Farm Bill and its classification under Schedule I of the Controlled Substances Act. It also includes external links and key literature references relevant to cannabidiol research and regulation, complementing the overall focus on CBD's effects, safety, and legal considerations within the full document.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 26, "doc_id": "doc_255", "num_chunks": 1, "chunk_id": "255::chunk_0", "document_index": 255, "latency_s": 0.6552585000026738, "prompt_toks": 396, "completion_toks": 62, "relevance_score": 3.9054835e-06}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    drug: delta-9-THC-COOH\npsychonaut_name: \npsychonaut_url: \nInfobox: \nSummary: \nContents: \nChemistry: \nPharmacology: \nSubjective effects: \nToxicity and harm potential: \nLegal status: \nSee also: \nExternal links: \nReferences: \nPhysical effects: \nCognitive effects: \nHistory and culture: \nLiterature: \nVisual effects: \nAuditory effects: \nMulti-sensory effects: \nTranspersonal effects: \nDisconnective effects: \nAfter effects: \nReagent results: \nPreparation methods: \nResearch: \nExamples: \nLegal issues: \nParadoxical effects: \nOther:\n\n\n                    Context: \n                    This chunk represents a comprehensive data template for the compound delta-9-THC-COOH, outlining key sections such as chemistry, pharmacology, effects, legal status, and research. It serves as the core informational structure within the larger webpage, facilitating detailed documentation and searchability of this specific drug profile.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_14", "document_index": 84, "latency_s": 0.829843700004858, "prompt_toks": 6301, "completion_toks": 75, "relevance_score": 3.844935e-06}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    Legal status\n\nInternationally, cannabidiol is not scheduled under the Convention on Psychotropic Substances or any other UN drug treaty.\n\nAustralia: Cannabidiol (in preparations for therapeutic use containing 2 per cent or less of other cannabinoids found in cannabis) was placed in Schedule 4 as a \"Prescription Only Medicine OR Prescription Animal Remedy\" in 2015. It was previously listed in Schedule 9 as a prohibited substance.[31]\n\nCanada: Cannabidiol is specifically listed in the Schedule II Controlled Drugs and Substances Act. However, in 2016 Canada’s \"Access to Cannabis for Medical Purposes Regulations\" came into effect. These regulations improve access to cannabis used for medicinal purposes, including CBD.[32]\n\nHong Kong: Illegal in Hong Kong since 1st February 2023, punishable by 7 years imprisonment.[33]\n\n\n                    Context: \n                    This section provides an overview of the international and national legal statuses of cannabidiol (CBD), detailing its scheduling and legal restrictions in various countries. It highlights regions where CBD is legal, regulated, or illegal, and specifies recent changes in jurisdictions like Australia, Canada, and Hong Kong. This information is crucial for understanding the legal considerations associated with CBD use and distribution worldwide.\n                "}
